We would love to hear your thoughts about our site and services, please take our survey here.
Just a matter of time before they both hopefully reward patient investors.
I commend your efforts and enthusiasm Porky9, but you jeopardise your credibility and frankly let your self down by feeling the need to, for no reason whatsoever, include derisory remarks about Avacta in your post. What is currently happening to 4D has got absolutely nothing to do with Avacta, in fact, I believe that both are seriously undervalued. My advice to you would be to take a more serious look at Avacta, in particular their therapeutics business. I'm invested in both co's and am happy to await my rewards on both.
The most depressing thing about what is happening just now is seeing the volume of people who just don't seem to be happy to make money without knowing and revelling in others losing money. What sort of person isn't satisfied with simply having their own success, but somehow needs to know that another person has lost out. No wonder the world we live in is so messed up.
I'd imagine that he'll add some extra info in the upcoming update. In the meantime we seem to have just fallen back to pre RNS prices so gap now closed for those who believe in gaps being filled. Hard to believe we are now at pre dose escalation SP...what an opportunity.
Looks like GSA have reduced their short position. https://shorttracker.co.uk
Utter nonsense @Chikungfunk...the RNS clearly praises the performance of the Affimer. The problem is very much with the antibody....it says so in black and white, hence they will replace it. RNS could just as easily be as a result of FDA validation. Stop embarrassing yourself
@Porky1 and @robins, I'm sure many investors will be thankful for your efforts, but I think you'll find that Adamski made a similar attempt at reaching out late December and indeed copied in the reply on this board. If you switch to thread view and go back to 31st December, you'll see the email and reply. They would not discuss Oliveira.
Website seems to have been updated tonight and now shows orders are possible where it said something like not available yet up until earlier today. Not sure if connected to Medusa19.
https://agiletestservices.com/products/lateral-flow-test
Another approx 1% confirmed as sold in last 4 weeks.
He's an ALBA MP and not SNP...and he's made more of a noise about his than any other MP. In fact, if it was not for him and his efforts, it's unlikely that this would even be in the press just now.
https://twitter.com/DomPosen/status/1477486416749809666
Dom Von Posen Tweet from earlier
There will clearly be an attempt by some one here (we know whop they are) to extract comments for the Times article to suggest that our CTDA application is one of many which have failed, and possibly failed some time ago, and that we have simply not been advised by AS.
Please just refer back to 15th Dec RNS and you'll see that AS stated "We are progressing with our application to the CTDA in order to put the AffiDx product on the market in the UK, as well as continuing to pursue commercial opportunities in Europe and further afield for the professional-use test. We also continue to work with our partners, Medusa 19 Healthcare, to obtain the CE mark for consumer self-testing for the product which is a critical next step in the commercialisation of the product."
Sounds very much the the application is still be processed.
Algo trades working overtime this morning to control the SP...just like Nasdaq yesterday.